NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.12B
This Quarter Return
+5.93%
1 Year Return
+50.66%
3 Year Return
+286.38%
5 Year Return
+525.06%
10 Year Return
+2,262.45%
AUM
$1.43B
AUM Growth
+$1.43B
(+11%)
Cap. Flow
+$171M
Cap. Flow
% of AUM
11.93%
Top 10 Holdings %
Top 10 Hldgs %
17.76%
Holding
226
New
47
Increased
72
Reduced
39
Closed
34
Top Buys
| 1 |
DMTK
DermTech, Inc. Common Stock
DMTK
|
$20.1M |
| 2 |
KalVista Pharmaceuticals
KALV
|
$15.3M |
| 3 |
TLIS
Talis Biomedical Corporation Common Stock
TLIS
|
$14.2M |
| 4 |
Exxon Mobil
XOM
|
$14M |
| 5 |
Instil Bio
TIL
|
$13.8M |
Top Sells
| 1 |
Teladoc Health
TDOC
|
$25.2M |
| 2 |
Iovance Biotherapeutics
IOVA
|
$23.6M |
| 3 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$13.8M |
| 4 |
Sarepta Therapeutics
SRPT
|
$13.5M |
| 5 |
Caesars Entertainment
CZR
|
$10.9M |
Sector Composition
| 1 | Healthcare | 47.74% |
| 2 | Technology | 10.12% |
| 3 | Industrials | 8.37% |
| 4 | Financials | 7.73% |
| 5 | Consumer Discretionary | 6.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
TG Therapeutics
TGTX
$4.65B
| $30.2M | 2.1% | 625,787 -2,385 | -0.4% | -$115K |
|
2
BridgeBio Pharma
BBIO
$9.89B
| $30.2M | 2.1% | 489,623 +77,852 | +19% | +$4.8M |
|
3
Repligen
RGEN
$6.88B
| $27.6M | 1.93% | 142,103 +11,612 | +9% | +$2.26M |
|
|
BHVN
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $25.7M | 1.79% | 375,654 +105,292 | +39% | +$7.2M |
|
|
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $24.9M | 1.74% | 270,631 -14,415 | -5% | -$1.33M |
|
6
argenx
ARGX
$43.6B
| $23.7M | 1.65% | 86,128 +2,800 | +3% | +$771K |
|
7
Guardant Health
GH
$8.41B
| $23.6M | 1.64% | 154,507 +2,459 | +2% | +$375K |
|
8
Krystal Biotech
KRYS
$4.27B
| $23.5M | 1.64% | 304,689 +71,146 | +30% | +$5.48M |
|
|
ARNA
9
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $22.8M | 1.59% | 327,942 +51,309 | +19% | +$3.56M |
|
10
NeoGenomics
NEO
$1.13B
| $22.7M | 1.58% | 470,452 +49,645 | +12% | +$2.39M |
|
11
Exact Sciences
EXAS
$8.98B
| $22.2M | 1.55% | 168,284 +16,538 | +11% | +$2.18M |
|
12
NovoCure
NVCR
$1.38B
| $21.3M | 1.48% | 161,137 +25,801 | +19% | +$3.41M |
|
13
Inspire Medical Systems
INSP
$2.77B
| $20.9M | 1.46% | 101,046 -4,049 | -4% | -$838K |
|
|
TPTX
14
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $20.7M | 1.44% | 218,847 +35,171 | +19% | +$3.33M |
|
15
Kornit Digital
KRNT
$669M
| $20.4M | 1.42% | 205,813 -50,521 | -20% | -$5.01M |
|
|
OSH
16
DELISTED
Oak Street Health, Inc.
OSH
| $20.2M | 1.41% | 372,841 +69,434 | +23% | +$3.77M |
|
17
Twist Bioscience
TWST
$1.63B
| $20.2M | 1.4% | 162,735 -16,140 | -9% | -$2M |
|
|
DMTK
18
DELISTED
DermTech, Inc. Common Stock
DMTK
| $20.1M | 1.4% | +396,506 | New | +$20.1M |
|
|
DCPH
19
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $20M | 1.4% | 446,674 +185,876 | +71% | +$8.33M |
|
20
Schrodinger
SDGR
$1.44B
| $20M | 1.39% | 261,662 +12,856 | +5% | +$981K |
|
21
Avantor
AVTR
$9.18B
| $19.7M | 1.37% | 680,900 +101,863 | +18% | +$2.95M |
|
22
Monolithic Power Systems
MPWR
$40B
| $19.3M | 1.34% | 54,589 -937 | -2% | -$331K |
|
23
Goldman Sachs
GS
$226B
| $19M | 1.32% | 57,961 +27,961 | +93% | +$9.14M |
|
|
ITCI
24
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $18.8M | 1.31% | 554,545 +164,256 | +42% | +$5.57M |
|
25
Zai Lab
ZLAB
$3.68B
| $18.4M | 1.29% | 138,222 +49,351 | +56% | +$6.58M |
|